Preclinical Evaluation of Sunitinib as a Single Agent in the Prophylactic Setting in a Mouse Model of Bone Metastases
BMC Cancer - United Kingdom
doi 10.1186/1471-2407-13-32
Full Text
Open PDFAbstract
Available in full text
Date
January 24, 2013
Authors
Publisher
Springer Science and Business Media LLC